Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ) decreases the risk of skin cancer and early skin aging caused by the sun
helps prevent sunburn if used as directed with other sun protection measures (see Directions ) decreases the risk of skin cancer and early skin aging caused by the sun
For sunscreen use: apply generously and evenly 15 minutes before sun exposure reapply at least every two hours use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: l...
protect the product in this container from excessive heat and direct sun
Drug Facts
| Active ingredients | Purpose |
|---|---|
| avobenzone 3.00% | Sunscreen |
| homosalate 5.00% | Sunscreen |
| octisalate 5.00% | Sunscreen |
| octocrylene 2.70% | Sunscreen |
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
For sunscreen use:
water\aqua\eau • butyloctyl salicylate • behenyl alcohol • nylon-12 • octyldodecyl neopentanoate • dimethicone • butylene glycol • myristyl myristate • cetyl esters • ascorbyl glucoside • polyethylene • ammonium acryloyldimethyltaurate/vp copolymer • citrus aurantium dulcis (orange) peel oil 1, pelargonium graveolens flower oil 1, cananga odorata flower oil 1, eugenia caryophyllus (clove) bud oil 1, rosa damascena flower oil 1, jasminum officinale (jasmine) oil 1, viola odorata flower/leaf extract, polianthes tuberosa extract, farnesol, eugenol, benzyl salicylate, citronellol, citral, benzyl benzoate, geraniol • rosa roxburghii fruit extract • paeonia albiflora (peony) root extract • molasses extract\saccharum officinarum\extrait de mélasse • citrus grandis (grapefruit) peel extract • triticum vulgare (wheat) germ extract • hordeum vulgare (barley) extract\extrait d'orge • palmaria palmata extract • punica granatum (pomegranate) fruit juice • hydrolyzed rice bran extract • gentiana lutea (gentian) root extract • curcuma longa (turmeric) root extract • sucrose 2 • glyceryl stearate • peg-100 stearate • peg-6 • glycerin • linoleic acid • salicylic acid • di-ppg-2 myreth-10 adipate • sodium hyaluronate • betaine • dipotassium glycyrrhizate • steareth-21 • trehalose • tocopheryl acetate • myristyl laurate • trisiloxane • di-c12-18 alkyl dimonium chloride • caprylyl glycol • squalane • myristyl alcohol • tromethamine • sodium dehydroacetate • hexylene glycol • sodium hydroxide • phenoxyethanol • mica <iln44031>
protect the product in this container from excessive heat and direct sun
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 77dc03a4-fbfc-e6a3-fe95-285bbae40d75 | Product name | 2 | 20250814 |
| d1c9d1af-bddd-448d-86f7-69052b7d5b47 | Product name | 1 | 20220627 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59427-112-01 | 2021-08-19 | C162847 | 48780-1 | c7ccaba7-1ccb-fd44-e053-dadaa90aa01b | Dr. Andrew Weil for Origins™ MEGA-BRIGHT SPF 30 SKIN TONE CORRECTING OIL FREE MOISTURIZER BROAD SPECTRUM |
| 59427-112-01 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-1ccb-fd44-e053-dadaa90aa01b | Dr. Andrew Weil for Origins™ MEGA-BRIGHT SPF 30 SKIN TONE CORRECTING OIL FREE MOISTURIZER BROAD SPECTRUM |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59427-112-01 | DR. ANDREW WEIL FOR ORIGINSMEGA-BRIGHT SPF 30 SKIN TONE CORRECTING oil FREE MOISTURIZER BROAD SPECTRUM SPF 30 | 1 in 1 CARTON | CREAM | 1 | 10 | |
| 59427-112-01 | DR. ANDREW WEIL FOR ORIGINSMEGA-BRIGHT SPF 30 SKIN TONE CORRECTING oil FREE MOISTURIZER BROAD SPECTRUM SPF 30 | 50 mL in 1 JAR | CREAM | 50 | 10 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59427-112 | DR. ANDREW WEIL FOR ORIGINS MEGA-BRIGHT SPF 30 SKIN TONE CORRECTING OIL FREE MOISTURIZER BROAD SPECTRUM SPF 30 (HOMOSALATE, OCTISALATE, AVOBENZONE, AND OCTOCRYLENE) CREAM [ORIGINS NATURAL RESOURCES INC.] | 10 | Current NDC, Legacy NDC, 2 package rows | 20241227_8e8c495e-d439-4735-a7cc-b44081b75b27.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| HOMOSALATE | ACTIVE INGREDIENT | V06SV4M95S | 1 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| HOMOSALATE | ACTIVE MOIETY | V06SV4M95S | 1 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| .alpha.-tocopherol acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| .beta.-citronellol, (r)- | INACTIVE INGREDIENT | P01OUT964K | 1 | |
| ammonium acryloyldimethyltaurate/vp copolymer | INACTIVE INGREDIENT | W59H9296ZG | 1 | |
| ascorbyl glucoside | INACTIVE INGREDIENT | 2V52R0NHXW | 1 | |
| BARLEY | INACTIVE INGREDIENT | 5PWM7YLI7R | 1 | |
| benzyl benzoate | INACTIVE INGREDIENT | N863NB338G | 1 | |
| benzyl salicylate | INACTIVE INGREDIENT | WAO5MNK9TU | 1 | |
| betaine | INACTIVE INGREDIENT | 3SCV180C9W | 1 | |
| butylene glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| butyloctyl salicylate | INACTIVE INGREDIENT | 2EH13UN8D3 | 1 | |
| cananga oil | INACTIVE INGREDIENT | 8YOY78GNNX | 1 | |
| caprylyl glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| cetyl esters wax | INACTIVE INGREDIENT | D072FFP9GU | 1 | |
| cholesterol | INACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| citral | INACTIVE INGREDIENT | T7EU0O9VPP | 1 | |
| citrus maxima fruit rind | INACTIVE INGREDIENT | 5NX3G75CA6 | 1 | |
| clove oil | INACTIVE INGREDIENT | 578389D6D0 | 1 | |
| di-ppg-2 myreth-10 adipate | INACTIVE INGREDIENT | 4IN301M0KJ | 1 | |
| dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| docosanol | INACTIVE INGREDIENT | 9G1OE216XY | 1 | |
| dulse | INACTIVE INGREDIENT | 7832HOY4ZQ | 1 | |
| eugenol | INACTIVE INGREDIENT | 3T8H1794QW | 1 | |
| farnesol | INACTIVE INGREDIENT | EB41QIU6JL | 1 | |
| GENTIANA LUTEA ROOT | INACTIVE INGREDIENT | S72O3284MS | 1 | |
| geraniol | INACTIVE INGREDIENT | L837108USY | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| glyceryl monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| glycyrrhizinate dipotassium | INACTIVE INGREDIENT | CA2Y0FE3FX | 1 | |
| hexylene glycol | INACTIVE INGREDIENT | KEH0A3F75J | 1 | |
| high density polyethylene | INACTIVE INGREDIENT | UG00KM4WR7 | 1 | |
| hyaluronate sodium | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| jasminum officinale flower | INACTIVE INGREDIENT | 0Q8K841432 | 1 | |
| linoleic acid | INACTIVE INGREDIENT | 9KJL21T0QJ | 1 | |
| mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| MOLASSES | INACTIVE INGREDIENT | LSU3YX0KZO | 1 | |
| MORUS NIGRA ROOT | INACTIVE INGREDIENT | 033456LFG1 | 1 | |
| myristyl alcohol | INACTIVE INGREDIENT | V42034O9PU | 1 | |
| myristyl laurate | INACTIVE INGREDIENT | 58U0NZN2BT | 1 | |
| myristyl myristate | INACTIVE INGREDIENT | 4042ZC00DY | 1 | |
| nylon-12 | INACTIVE INGREDIENT | 446U8J075B | 1 | |
| octyldodecyl neopentanoate | INACTIVE INGREDIENT | X8725R883T | 1 | |
| orange oil | INACTIVE INGREDIENT | AKN3KSD11B | 1 | |
| PAEONIA LACTIFLORA ROOT | INACTIVE INGREDIENT | 3Z3866YW6P | 1 | |
| peg-100 stearate | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| pelargonium graveolens flower oil | INACTIVE INGREDIENT | 3K0J1S7QGC | 1 | |
| phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| polyethylene glycol 300 | INACTIVE INGREDIENT | 5655G9Y8AQ | 1 | |
| POMEGRANATE JUICE | INACTIVE INGREDIENT | 99S671U9KB | 1 | |
| rosa damascena flower oil | INACTIVE INGREDIENT | 18920M3T13 | 1 | |
| rosa roxburghii fruit | INACTIVE INGREDIENT | CVT1AA87FF | 1 | |
| salicylic acid | INACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| scutellaria baicalensis root | INACTIVE INGREDIENT | 7J95K7ID2S | 1 | |
| sodium dehydroacetate | INACTIVE INGREDIENT | 8W46YN971G | 1 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 1 | |
| squalane | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| steareth-21 | INACTIVE INGREDIENT | 53J3F32P58 | 1 | |
| sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 | |
| trehalose | INACTIVE INGREDIENT | B8WCK70T7I | 1 | |
| trisiloxane | INACTIVE INGREDIENT | 9G1ZW13R0G | 1 | |
| tromethamine | INACTIVE INGREDIENT | 023C2WHX2V | 1 | |
| turmeric | INACTIVE INGREDIENT | 856YO1Z64F | 1 | |
| viola odorata flowering top | INACTIVE INGREDIENT | 04BPC87I4H | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| wheat germ | INACTIVE INGREDIENT | YR3G369F5A | 1 | |
| wine grape | INACTIVE INGREDIENT | 3GOV20705G | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59427-112 | 59427-112-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| orange oil | ORANGE OIL, COLD PRESSED | AKN3KSD11B | ELIXIR / ORAL | 0.24 mg | ||
| sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| tromethamine | TROMETHAMINE | 023C2WHX2V | GEL / TOPICAL | 56 mg | ||
| butylene glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| sucrose | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| butylene glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| .alpha.-tocopherol acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| clove oil | CLOVE OIL | 578389D6D0 | SUSPENSION / ORAL | 0.1 mg/5ml | ||
| sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CREAM / TOPICAL | 69 mg | ||
| sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| sucrose | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| sucrose | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| benzyl benzoate | BENZYL BENZOATE | N863NB338G | INJECTION / INTRAMUSCULAR | 1500 mg | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CREAM / TOPICAL | 69 mg | ||
| sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| clove oil | CLOVE OIL | 578389D6D0 | SUSPENSION / ORAL | 0.1 mg/5ml | ||
| sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| orange oil | ORANGE OIL, COLD PRESSED | AKN3KSD11B | TABLET / SUBLINGUAL | NA | ||
| cetyl esters wax | CETYL ESTERS WAX | D072FFP9GU | CREAM / TOPICAL | 10.3 %w/w | ||
| sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| sucrose | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| docosanol | DOCOSANOL | 9G1OE216XY | AEROSOL, FOAM / TOPICAL | 1.1 %w/w | ||
| peg-100 stearate | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / TOPICAL | 552 mg | ||
| sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| benzyl benzoate | BENZYL BENZOATE | N863NB338G | INJECTION / INTRAMUSCULAR | 1500 mg | ||
| sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| benzyl benzoate | BENZYL BENZOATE | N863NB338G | INJECTION, SOLUTION / INTRAMUSCULAR | 750 mg | ||
| orange oil | ORANGE OIL, COLD PRESSED | AKN3KSD11B | POWDER, FOR SUSPENSION / ORAL | 4 mg | ||
| sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| cholesterol | CHOLESTEROL | 97C5T2UQ7J | CREAM / TOPICAL | 1 %w/w | ||
| sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| sucrose | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| hyaluronate sodium | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| orange oil | ORANGE OIL, COLD PRESSED | AKN3KSD11B | LIQUID / ORAL | 50 mg | ||
| cetyl esters wax | CETYL ESTERS WAX | D072FFP9GU | CREAM / TOPICAL | 10.3 %w/w | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | CREAM / TOPICAL | 54.5 %w/w | ||
| docosanol | DOCOSANOL | 9G1OE216XY | SOLUTION / TOPICAL | 1.1 %w/w | ||
| docosanol | DOCOSANOL | 9G1OE216XY | AEROSOL, FOAM / TOPICAL | 1.1 %w/w | ||
| benzyl benzoate | BENZYL BENZOATE | N863NB338G | SOLUTION / INTRAMUSCULAR | 447 mg | ||
| sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DR. ANDREW WEIL FOR ORIGINS MEGA-BRIGHT SPF 30 SKIN TONE CORRECTING oil FREE MOISTURIZER BROAD SPECTRUM SPF 30 | HOMOSALATE, OCTISALATE, AVOBENZONE, AND OCTOCRYLENE | ORIGINS NATURAL RESOURCES INC. | 8e8c495e-d439-4735-a7cc-b44081b75b27 | 2024-12-25 | Warnings | 59427-112-01 59427-112 59427011201 2a15c3c3-d929-ae5c-e063-6294a90a6d65 8e8c495e-d439-4735-a7cc-b44081b75b27 |
Adverse event summaries are temporarily unavailable. Other product information remains available.